Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study
"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study.
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice.
Autorzy:
Cortellini A; Medical Oncology, St Salvatore Hospital, University of L'Aquila, L'Aquila, Italy, .; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy, . Cannita K; Medical Oncology, St Salvatore Hospital, University of L'Aquila, L'Aquila, Italy, . Parisi A; Medical Oncology, St Salvatore Hospital, University of L'Aquila, L'Aquila, Italy, .; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy, . LanfiutiBaldi P; Medical Oncology, St Salvatore Hospital, University of L'Aquila, L'Aquila, Italy, . Venditti O; Medical Oncology, St Salvatore Hospital, University of L'Aquila, L'Aquila, Italy, . D'Orazio C; Medical Oncology, St Salvatore Hospital, University of L'Aquila, L'Aquila, Italy, .; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy, . Dal Mas A; Department of Pathology, St Salvatore Hospital L'Aquila, L'Aquila, Italy. Calvisi G; Department of Pathology, St Salvatore Hospital L'Aquila, L'Aquila, Italy. Giordano AV; Diagnostic and Interventional Radiology, St Salvatore Hospital, University of L'Aquila, L'Aquila, Italy. Vicentini V; Department of Hepatobiliar-Pancreatic and Emergency Surgery, St Salvatore Hospital, L'Aquila, Italy. Vicentini R; Department of Hepatobiliar-Pancreatic and Emergency Surgery, St Salvatore Hospital, L'Aquila, Italy. Felicioni L; Oncological and Cardiovascular Molecular Medicine Department, Center for Excellence on Ageing and Translational Medicine (CeSI-MeT), University of Chieti-Pescara, Chieti, Italy. Marchetti A; Center of Predictive Molecular Medicine, Center for Excellence on Ageing and Translational Medicine (CeSI-MeT), University of Chieti-Pescara, Chieti, Italy. Buttitta F; Oncological and Cardiovascular Molecular Medicine Department, Center for Excellence on Ageing and Translational Medicine (CeSI-MeT), University of Chieti-Pescara, Chieti, Italy. Russo A; Medical Oncology Unit, Department of Surgical, Oncological and Stomatological Sciences, University of Palermo, Palermo, Italy. Ficorella C; Medical Oncology, St Salvatore Hospital, University of L'Aquila, L'Aquila, Italy, .; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy, .
Pokaż więcej
Źródło:
OncoTargets and therapy [Onco Targets Ther] 2019 Mar 25; Vol. 12, pp. 2159-2170. Date of Electronic Publication: 2019 Mar 25 (Print Publication: 2019).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
